newsroom.questdiagnostics.comQuest Diagnostics Newsroom - Newsroom

This site uses cookies. To find out more, see our Cookies Policy x This site uses cookies. To find out more, see our Cookies Policy Newsroom Toggle navigation Home News Releases News Releases RSS Feeds Media Coverage Health Trends® Quest Consumer Company Information At a Glance Awards Contact Email Alerts News & Media 16 Clinical Laboratory Predictions for 2024 Read More Alzheimer’s blood tests could change research, treatment Read More The new CEO at Quest: A first look at Jim Davis Read More In Case You Missed It: The Latest News from Quest Diagnostics Please check back regularly for the latest information. Read More ‹ › Quest Diagnostics empowers people to take action to improve health outcomes. Health Trends Quest Consumer Press Releases Email Alerts Digital Assets Company Overview Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. Learn More Latest News Email Alerts 05 07 2024 Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company’s strategy, performance... 05 06 2024 Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announced today that Murali Balakumar, a veteran information technology healthcare business leader, has been... 05 01 2024 Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI Transaction is part of wide-ranging collaboration to combine Quest’s oncology expertise and scale with PathAI’s AI and digital pathology innovations to speed diagnosis, improve quality and reduce... All Releases Newsroom Quest Blog - Empowering better health with diagnostic insights. View Posts Media Coverage 02 16 2024 New Melanoma Metastasis Risk Prediction Tool Debuts Dermatology Times Quest Diagnostics on Tuesday announced a new tool available to dermatologists for making treatment decisions for patients with melanoma. The gene expression test, MelaNodal Predict, is based on technology developed by the oncology biotechnology company SkylineDx and researchers at Mayo Clinic. 02 13 2024 Quest announces 1st PFAS blood text for consumers. What are forever chemicals? The Daytona Beach News-Journal Years of exposure to nonstick cookware, fast-food packaging, fire-fighting gear and water-resistant household products have resulted in increased levels of PFAS, also known as "forever chemicals," in practically every American’s bloodstream. Quest Diagnostics announced Monday the first "consumer-initiated, physician-ordered blood-draw test for PFAS chemicals." The test, which you order online, will be available from most of Quest’s approximately 2,100 diagnostic centers in the country and will include (if desired) a separate telephone consultation with a licensed physician to go over the results and ways to reduce the exposure risk. All Coverage Quest Diagnostics Health Trends™ Quest Diagnostics Health Trends™ is a series of reports from Quest Diagnostics on health conditions affecting a large number of Americans. Published in peer-reviewed journals, at scientific conferences and widely as a public service, the reports are designed to inform health care professionals, patients and policymakers about the status of the nation’s health. See All At A Glance... More than 6,600 patient access points, the most extensive network in the U.S., including phlebotomists in physician offices and more than 2,250 of our own patient service centers. A medical and scientific staff of more than 600 M.D.s and Ph.Ds. Logistics capabilities, that include approximately 3,750 courier vehicles and 25 aircraft that collectively make tens of thousands of stops daily. Media Resources Journalists may contact Quest Diagnostics by emailing...